This clinical trial is focused on studying the effects of a medication called Dexmedetomidine on the brain. The diseases being studied include neurodegenerative disease, delirium, and acute neurological disease. The purpose of the study is to understand how this medication influences brain functions such as blood flow and the movement of cerebrospinal fluid, which is a clear liquid surrounding the brain and spinal cord. The study will use a technique called functional Magnetic Resonance Imaging (MRI) to observe these effects.
Participants in the study will receive Dexmedetomidine through an intravenous infusion, which means it will be administered directly into a vein. The study will observe changes in brain activity and blood flow while participants are awake and under different levels of sedation caused by the medication. The study will also use electroencephalography (EEG), a method to record electrical activity of the brain, to gather more information about how the brain functions during these different states.
The study aims to gather data on how Dexmedetomidine affects brain signals and other bodily functions, such as blood pressure and heart rate. This information will help researchers understand the potential benefits and effects of the medication on brain health, particularly in relation to the diseases being studied. The study will also look at how the medication affects various biomarkers, which are substances in the body that can indicate how well the body is functioning or responding to treatment.



Finland